ABSTRACT NUMBER: ESOC2026A309 SEX DIFFERENCES IN OUTCOMES OF LATE-WINDOW TENECTEPLASE THROMBOLYSIS——A SECONDARY ANALYSIS OF THE TRACE-III RANDOMIZED TRIAL
Liyuan Wang, Zhixin Cao, Jinfeng Yin, Aoming Jin, Manjun Hao, Shuangzhe Wu, Yongjun Wang, Yunyun Xiong · 2026
Read ABSTRACT NUMBER: ESOC2026A309 SEX DIFFERENCES IN OUTCOMES OF LATE-WINDOW TENECTEPLASE THROMBOLYSIS——A SECONDARY ANALYSIS OF THE TRACE-III RANDOMIZED TRIAL by Liyuan Wang, Zhixin Cao, Jinfeng Yin, Aoming Jin, Manjun Hao, Shuangzhe Wu, Yongjun Wang, Yunyun Xiong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146070.txt.
Description
Liyuan Wang and co-authors report a 2026 conference study on sex gaps in late-window clot drug care for major stroke. The TRACE-III trial tested the drug tenecteplase from four and a half to twenty-four hours after onset in patients who could not get clot removal. Whether women gain as much as men was unclear.
Women made up about a third of the more than five hundred trial patients in China. Among men, the drug raised top-level recovery at ninety days by a clear margin over standard care. Among women, rates sat close between drug and standard care. No firm proof of a sex split appeared in the checks. The authors present the gap as a pattern to probe, not a settled rule.
Catalog record
| CREATOR | Liyuan Wang, Zhixin Cao, Jinfeng Yin, Aoming Jin, Manjun Hao, Shuangzhe Wu, Yongjun Wang, Yunyun Xiong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |